ECB Call: Looking for PEPP increase of €500bn and extension beyond 2020

Macro

Christopher Dembik

Head of Macro Analysis

Summary:  We are onside with consensus in expecting an increase of the PEPP of EUR 500bn and its extension until 2021. The ECB is also likely to take note of the most recent data and downgrade its macroeconomic projections for this year. Any explicit reference to long term deviation from capital keys would be very welcome by market participants as it would signal that the ECB is ready to show flexibility over time to help countries most affected by the crisis and to avoid a widening of sovereign spreads.


 

The ECB systemic stress indicator initially developed by Hollo, Kremer and Lo Duca in 2012, and based on fifteen financial stress measures, points out that further support from the ECB is needed to limit financial issues that could slow down the recovery. Though it has receded from its annual peak reached in mid-March, it remains in risk-zone territory at 0.25. To address ongoing tensions and absorb all the new coronavirus debt issued by euro area countries, we expect the ECB to increase the size of its new Pandemic Emergency Purchase Programme (PEPP) from EUR 750bn to EUR 1.25tr and extend it beyond 2020, at least until June/September 2021.

Following the release of the worst euro area GDP figure on record in Q1 (at minus 3.8% QoQ) and given the second quarter print will be even worse due to the impact of strict lockdown, the ECB is likely to downward its macroeconomic projections for 2020. One month ago, the ECB presented different growth scenarios, with GDP contraction reaching -5% to -12% before a rebound in 2021 between +4% to +6%. We think the baseline growth forecast should be close to the most severe scenario, around -10% this year. The amplitude of the rebound in 2021 will be highly dependent on fiscal policy and the steady implementation of the EU recovery fund worth EUR 750bn presented last week by the EC. In this regard, uncertainty remains since the political bargaining between member states has just started. Thought it is a positive step forward, this is not the “Hamilton moment” expected by many European enthusiasts. It is ill-timed – the peak of the stimulus package will be reached only in 2024! – and it is insufficient in terms of amounts allocated to cope with the economic disaster, especially in countries most hit.

During the press conference, any explicit reference to long term deviation from capital keys could be bullish for the market. It would constitute a clear signal that the ECB is eager to show flexibility in running its PEPP and is committed to do whatever it takes to avoid a widening of euro area sovereign spreads.

We cannot exclude the possibility the ECB could give indications of increase in supranational bonds purchases, whenever it will be the right time, in order to absorb debt issuance linked to the EU recovery fund. It would also have the advantage of mitigating issuer limit since the relative share of sovereign bonds would automatically decrease.

Finally, as it clearly appears the initial shock from the COVID-19 outbreak is mostly deflationary, the ECB could put back on the table the topic of the inflation target that is initially part of its strategy review. A more symmetrical inflation target of, say, 1.5-2.5% in the medium run with a goal to average 2% in the long run, could be clearer and simpler than the current definition. It would also substantially reinforce the credibility of the ECB’s forward guidance in order to address growing deflationary risks.

ECB Post-pandemic policy options:

In case further monetary policy easing would be needed in the long run, the ECB is not running out of ammunition. Below, we have ranked the potential new measures from most likely to least likely to occur:

Lower TLTRO rate: TLTRO is one of the most powerful tools in the ECB toolbox. It is the least politically sensitive – the latest ECB minutes showed broad support to TLTRO – with the biggest positive economic impact and little or no stigma attached. Further TLTRO cut is on the top of the agenda if the ECB needs to act further.

Bank loans purchases: The ECB can also decide to buy private assets. Purchase of bank loans (corporate loans), as the Federal Reserve is doing with the Main Street Lending Facility, could be one option to encourage banks to give money more freely to businesses in need of a loan and free them of most of the associated risk.

HY purchases: The ECB might need to include HY bonds in its PEPP, focusing primarily on fallen angels, if the euro area faces a wave of credit downgrade in the coming months as the real impact of the crisis will be more visible.

More negative rates: Unlikely due to the negative consequences on banks’ profitability.

Yield Curve Control: It is mostly an exit strategy in case the ECB would like to run the economy hot when the recovery will materialize while preventing yields from rising too fast. The incremental approach could consist in targeting front-end yields (i.e. up to two years) to make sure borrowing costs would remain low. However, it faces both technical and legal constraints. YCC can work fine in true monetary unions, like the U.S. or Japan, but in the euro area it would imply that the ECB targets several yield curve simultaneously  - which would seriously complicate the task. On the top of that, the ECB is legally bounded to buy assets provided that it respects principle of proportionality – which would not be the case with YCC.

OMT programme: It is still part of the toolbox, but it is a last-resort measure that could be activated only in case of an unexpected and sudden credit crunch that would limit member states’ access to public markets.

Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Pty Ltd ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as CFDs and Margin FX products may result in your losses surpassing your initial deposits. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.